Demodex blepharitis: Breaking the Cycle with Advanced Treatments
Christopher E. Starr, MD, discusses how to identify, diagnose, and effectively treat Demodex blepharitis in both preoperative cataract patients and contact lens wearers, highlighting the importance of eradicating these mites using FDA-approved lotilaner ophthalmic solution to improve visual outcomes and quality of life.
EP. 1: Detecting Demodex Blepharitis during preop cataract surgical visit
June 10th 2025A panelist discusses how demodex blepharitis presents with distinctive symptoms like eyelash itching, colorettes at the base of lashes, and can significantly affect pre-surgical cataract measurements, requiring treatment before proceeding with surgery.
EP. 2: Preop Visually Significant OSD: Treatment Strategy and Outcomes
June 10th 2025A panelist discusses how treating ocular surface disease and demodex blepharitis before cataract surgery led to improved refractive measurements, resolved corneal staining, and enabled successful multifocal IOL implantation in a patient who had previously shown irregularly irregular topography patterns.
EP. 3: Demodex Blepharitis in a Contact Lens Wearer
June 10th 2025A panelist discusses how demodex blepharitis frequently co-occurs with other ocular surface conditions in younger patients, as illustrated by a 35-year-old contact lens wearer who presented with recurrent styes, contact lens intolerance, and a history of rosacea.
EP. 4: Demodex Blepharitis in a Contact Lens Wearer: Treatment Plan and Outcomes
June 10th 2025A panelist discusses how treating demodex blepharitis with Lotilaner not only eliminates the anterior blepharitis symptoms but also improves meibomian gland function, with low recurrence rates after treatment and significant benefits for patient comfort and quality of life.
